Dorit Reiss

Dorit Reiss

academic United States

Dorit Reiss is a professor of law at the University of California, Hastings College of the Law, where she specializes in health law, vaccine policy, and the legal implications of immunization practices. She is known for her advocacy in the public health arena, particularly concerning vaccine safety and the importance of immunization in preventing disease outbreaks. Reiss has been a vocal critic of anti-vaccine movements and has emphasized the necessity of science-based policies in public health decision-making. Her insights have been sought in discussions surrounding vaccine legislation and the implications of misinformation in health policy.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
44,400
Power
157$
Sentiment
6.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Ukraine 1 6.00 0.10% +0% 43,733,762 44,400 $155,000 157$
Totals 1 43,733,762 44,400 $155,000 157$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

United States United States: Dorit Reiss, a professor of law at UC Law San Francisco, told CNN that the action 'serves a broader anti-vaccine agenda.' 4

CNN: Vaccine Injury Compensation Program: Kennedy announces plan to reform

United States United States: Dorit Reiss is a professor of law at UC Law San Francisco, focusing on legal and policy issues related to vaccines. 5

CNN: Former leader of anti-vaccine group founded by RFK Jr. to present at first meeting of new CDC vaccine advisers

Guyana Guyana: Dorit Reiss, a vaccine law expert, stated that the ACIP is an expert committee and not a political one. 6

Stabroek News: US Health Secretary Kennedy guts vaccine advisory committee

United States United States: Dorit Reiss, a professor of law at UC Law San Francisco, commented on the FDA's changing standards for Covid-19 vaccine boosters. 6

CNN: HHS to require placebo testing of ‘all new vaccines,’ raising questions about approval of updated Covid-19 shots